![Susan Abu-Absi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Abu-Absi
Directeur des opérations chez
AURA BIOSCIENCES, INC.
Fortune : 965 803 $ au 31/08/2026
Profil
Susan Abu-Absi is Chief Operating Officer at Aura Biosciences, Inc. since 2026.
Formerly, Chief Operating Officer at Be Biopharma, Inc. from 2025 to 2026; Chief Technology & Manufacturing Officer at 2seventy Bio, Inc. from 2022 to 2024; Head-Process & Analytical Development at Genetix Biotherapeutics, Inc.; and Member-Process Sciences Organization at Bayer HealthCare.
Education includes a doctorate from the University of Minnesota and an undergraduate degree from the University of Toledo (Ohio).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,13 % | 01/09/2026 | 134 513 ( 0,13 % ) | 965 803 $ | 31/08/2026 |
Postes actifs de Susan Abu-Absi
| Sociétés | Poste | Début |
|---|---|---|
| AURA BIOSCIENCES, INC. | Directeur des opérations | 10/08/2026 |
Anciens postes connus de Susan Abu-Absi
| Sociétés | Poste | Fin |
|---|---|---|
Be Biopharma, Inc.
 Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Directeur des opérations | 01/06/2026 |
| 2SEVENTY BIO, INC. | Directeur Technique/Scientifique/R&D | 01/05/2024 |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Corporate Officer/Principal | - |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Susan Abu-Absi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo (Ohio)
 University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
